Catalano Onofrio A, Samir Anthony E, Sahani Dushyant V, Hahn Peter F
Division of Abdominal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, 55 Fruit St, WHT 270, Boston, MA 02114, USA.
Radiology. 2008 Jun;247(3):738-46. doi: 10.1148/radiol.2473070785. Epub 2008 Apr 15.
To retrospectively determine if pixel histogram analysis of unenhanced computed tomographic (CT) images can be used to distinguish angiomyolipomas (AMLs) with minimal fat from clear cell renal cell carcinomas (CCRCCs).
The human studies committee approved this HIPAA-complaint study, with waiver of informed consent. Patients with pathologically proved AMLs lacking visible macroscopic fat at CT and patients with pathologically proved CCRCCs were included. Lesions were measured, and a histogram (number of pixels with each attenuation) was calculated electronically within a central region of interest. The percentage of pixels below the attenuation thresholds -20 HU and 10 HU was calculated in both cohorts. The unpaired Student t test was used to compare the average percentage of subthreshold pixels at each threshold. P < .05 indicated a significant difference. The number of lesions with more than the selected percentage of subthreshold pixels was calculated in both groups, and the chi(2) test was used to test the significance of differences between cohorts. The area under the receiver operating characteristic (ROC) curve was used to determine if any percentage of subthreshold pixels could be used to differentiate between the two cohorts.
There were 22 patients with pathologically proved AMLs lacking visible macroscopic fat on CT images. Tuberous sclerosis affected three of these patients. Mean maximal transverse lesion diameter was 20 mm (range, 11-38 mm). There were 28 patients in the CCRCC comparison group. Mean maximal transverse lesion diameter was 26 mm (range, 15-36 mm). Neither the Student t test (P > .2 for all thresholds <0 HU) nor the chi(2) test (P > .15 for all thresholds <0 HU) revealed a significant difference between cohorts. A lesion with more low-attenuation pixels was significantly more likely to be characterized as CCRCC than as AML with ROC curve analysis.
Once AMLs with visible fat on CT images are excluded, pixel histogram analysis cannot be used to distinguish between AMLs and CCRCCs.
回顾性确定未增强计算机断层扫描(CT)图像的像素直方图分析是否可用于区分脂肪含量极少的血管平滑肌脂肪瘤(AML)与透明细胞肾细胞癌(CCRCC)。
人类研究委员会批准了这项符合健康保险流通与责任法案(HIPAA)的研究,并豁免了知情同意。纳入了经病理证实的CT图像上无可见宏观脂肪的AML患者以及经病理证实的CCRCC患者。对病变进行测量,并在感兴趣的中心区域内通过电子方式计算直方图(每个衰减值的像素数量)。计算两组中衰减阈值低于-20 HU和10 HU的像素百分比。采用非配对学生t检验比较每个阈值下亚阈值像素的平均百分比。P <.05表示存在显著差异。计算两组中亚阈值像素百分比超过选定百分比的病变数量,并采用卡方检验检验两组之间差异的显著性。采用受试者操作特征(ROC)曲线下面积来确定是否有任何亚阈值像素百分比可用于区分两组。
有22例经病理证实的CT图像上无可见宏观脂肪的AML患者。其中3例患者患有结节性硬化症。病变的平均最大横径为20 mm(范围为11 - 38 mm)。CCRCC比较组有28例患者。病变的平均最大横径为26 mm(范围为15 - 36 mm)。学生t检验(所有阈值<0 HU时P>.2)和卡方检验(所有阈值<0 HU时P>.15)均未显示两组之间存在显著差异。通过ROC曲线分析,低衰减像素较多的病变被判定为CCRCC的可能性显著高于AML。
一旦排除CT图像上有可见脂肪的AML,像素直方图分析无法用于区分AML和CCRCC。